The College on Problems of Drug Dependence (CPDD)—the longest standing organization in the U.S. that addresses problems of drug dependence, misuse, and abuse—will hold its 2019 annual scientific meeting in San Antonio, TX. This will be the 81st annual meeting for the CPDD, which actively promotes scientific research in all aspects of substance abuse and addictive disorders.
More than 20 RTI researchers will either attend, have their work presented, and/or lead poster sessions, oral communications, and symposiums during the five-day conference, including:
Poster Session I
Sunday, June 16, 11:00 AM−1:00 PM
How long should pharmacotherapy last for the treatment of opioid use disorder? Results from a 12-month observational study
Arnie Aldridge, et al.
Poster Session II
Monday, June 17, 8:00 AM−10:00 AM
Risk factors associated with early injection drug use initiation among a cohort of people who inject drugs
Alex Kral, Lynn Wenger, et al.
Symposium XI: SOMATICS: Addressing the Opioid Crisis in Vulnerable Populations
Tuesday, June 18, 10:00 AM−12:00 PM
Economic analyses of pharmacotherapy for opioid treatment in criminal justice settings: Results from the SOMATICS collaborative
Gary Zarkin
Poster Session III
Tuesday, June 18, 12:00 PM−2:00 PM
Innovative solutions to opioid overdose mortality crisis: Safe consumption sites
Alex Kral, Lynn Wenger, Barrot Lambdin, et al.
Oral Communications 23: Infectious Disease Innovations
Wednesday, June 19, 1:30 PM−3:30 PM
The effects of needle gauge and syringe barrel capacity on syringe cleaning and possible HIV/HCV transmission
William Zule, Sarah Rhea, David Schley, Georgia Mitchell, Georgiy Bobashev
Learn more about RTI expert presentations and see the full schedule in the 2019 CPDD Program Book.
Through associations with academia, government agencies such as the National Institue on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA), and private industry organizations, CPDD promotes scientific discoveries in addictive disorders, helps inform public policy, and advocates the need for continued research and advancement on addictive diseases.
Learn more about RTI’s substance abuse research.
